Evaluation of N-SWEAT Patch for Treatment of Primary Axillary Hyperhidrosis or Excessive Axillary Sweating
An Evaluation of the Safety and Effectiveness of the N-SWEAT Patch for the Treatment of Primary Axillary Hyperhidrosis or Excessive Axillary Sweating
Sponsor: Candesant Biomedical, Inc.
A NA clinical study on Primary Axillary Hyperhidrosis, this trial is completed. The trial is conducted by Candesant Biomedical, Inc. and has accumulated 7 data snapshots since 2020. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Oct 2023 — Jul 2024 [monthly]
Completed NA
Status: Active Not Recruiting → Completed
-
Sep 2021 — Oct 2023 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Apr 2021 — Sep 2021 [monthly]
Recruiting NA
Status: Withheld → Recruiting · Phase: None → NA
▶ Show 2 earlier versions
-
Jan 2021 — Apr 2021 [monthly]
Withheld
-
Nov 2020 — Jan 2021 [monthly]
Withheld
First recorded
Oct 2020
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Candesant Biomedical, Inc.
For direct contact, visit the study record on ClinicalTrials.gov .